Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • FIPB approves...

    FIPB approves Aurobindo Pharma's FDI proposal

    Written by savita thakur thakur Published On 2016-06-16T17:20:43+05:30  |  Updated On 16 Jun 2016 5:20 PM IST
    FIPB approves Aurobindo Pharmas FDI proposal

    The Foreign Investment Promotion Board (FIPB) has approved two foreign direct investment (FDI) proposals, including that of Aurobindo Pharma, an official statement said.


    "Based on the recommendations of FIPB in its meeting held on May 20, 2016, the government has approved two FDI proposals involving FDI of Rs 2.19 crore," said the finance ministry statement.


    The FDI proposal of Aurobindo Pharma is worth Rs 2.19 crore while the one from Sterling Commerce Solutions India was for approval to act as an investing company, the statement said.


    FIPB has recommended another proposal from Holcim India for approval of the Cabinet Committee on Economic Affairs.


    The proposal seeks approval for Ambuja Cements to acquire 24 per cent shares in its holding company, Holcim India, it said.


    Moreover, Vodafone India's proposal to acquire 100 per cent share capital of You Broadband India has been deferred, it added.

    Aurobindo PharmaFDIFDI proposalFIPBFIPB approvalForeign Investment Promotion Board
    Source : IANS

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok